22. On December 6, 2013, the Respondent ordered UDS that was positive for
hydrocodone and fentanyl but negative for Soma, which the Respondent had been
prescribing. The Respondent did not address this inconsistent finding in his subsequent
progress note or alter his prescribing of Soma in view of these inconsistent findings.

23. |The Respondent's chart contains a letter to Patient A, dated December 23,
2013, that addresses Patient A's report that he had lost his "prescriptions" while staying
in a hotel. The Respondent's letter states that "repeat events will incline us to assess
the matter(s) otherwise and act accordingly."

24, The Respondent continued to refill Patient A's monthly amounts of opioid
and non-opioid medications on an earlier-than-monthly basis, however.

25. On April 8, 2014, the Respondent ordered UDS that was positive for
benzodiazepines (Xanax). The Respondent did not prescribe Xanax for Patient A. The
Respondent did not address this inconsistent finding in his progress note.

26. Throughout the remainder of the treatment period, the Respondent
administered a variety of injection therapies and continued prescribing the medication
regimen noted above. The Respondent ordered UDS on April 30, 2014, and July 8,
2014, Patient A's UDS findings were largely consistent with the Respondent's
prescribing with the exception of a negative finding for Soma on July 8, 2014.

Patient B

27. |The Respondent treated Patient B, a man in his mid-50s, for low back pain
and knee pain. Patient B is a close family relative of Patient C, infra. The Respondent's
medical records note treatment provided from May 2013 through August 2014. During

this treatment period, the Respondent administered various knee injections and also
